Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT03367884

Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer

Neck Dissection Versus Radiotherapy for Cervical Lymph Node Metastasis in Advanced Hypopharyngeal Carcinoma With Poor Response to Induction Chemotherapy : A Randomized Controlled Prospective Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Tianjin Medical University Cancer Institute and Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

At the time of diagnosis, approximately 60%-80% of patients with hypopharyngeal cancer are found with cervical lymph node metastasis. Cervical nodal metastasis is an important prognostic factor in hypopharyngeal cancer. Induction chemotherapy is frequently used in advanced hypopharynx cancer. However, sometimes CR was obtained at the tumor's primary site but not in the palpable lymph nodes in the neck, the large cervical lymph node metastasis poorly responded to induction chemotherapy in a considerable percentage of patients. At present, patients with primary tumor achieved CR preferred to receive definitive radiotherapy no matter cervical lymph node metastasis SD or progression. But, radiotherapy was poor effective to the big cervical lymph node metastasis, because the inner of big cervical lymph node metastasis was hypoxic and necrosis. The investigators conducted a prospective, randomised trial to compare neck dissection with definitive radiotherapy for advanced hypopharyngeal cancer cervical lymph node metastasis with poor response to induction chemotherapy.

Conditions

Interventions

TypeNameDescription
PROCEDURENeck dissection followed by radiotherapy(50Gy) according to risk factorsNeck dissection followed by radiotherapy(50Gy) according to risk factors
RADIATIONDefinitive radiotherapyDefinitive radiotherapy (70Gy)

Timeline

Start date
2018-01-01
Primary completion
2024-01-01
Completion
2028-01-01
First posted
2017-12-11
Last updated
2017-12-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03367884. Inclusion in this directory is not an endorsement.